Milestone Pharmaceuticals (MIST) Cash & Current Investments: 2021

Historic Cash & Current Investments for Milestone Pharmaceuticals (MIST) over the last 1 years, with Dec 2021 value amounting to $114.1 million.

  • Milestone Pharmaceuticals' Cash & Current Investments fell 17.15% to $117.1 million in Q3 2022 from the same period last year, while for Sep 2022 it was $448.7 million, marking a year-over-year change of. This contributed to the annual value of $114.1 million for FY2021, which is N/A change from last year.
  • Latest data reveals that Milestone Pharmaceuticals reported Cash & Current Investments of $114.1 million as of FY2021.
  • In the past 5 years, Milestone Pharmaceuticals' Cash & Current Investments ranged from a high of $114.1 million in FY2021 and a low of $114.1 million during FY2021.
  • Its 1-year average for Cash & Current Investments is $114.1 million, with a median of $114.1 million in 2021.